Arlene D'Silva
Dr D’Silva is the lead Postdoctoral Research Fellow/Lecturer for the Paediatric Neurology Research Group, UNSW and Neuromuscular Research Group, Sydney Children’s Hospital Randwick. Her research focusses on interrogating biological mechanisms in neurogenetic diseases by harnessing latest innovations in genomic, transcriptomic, and proteomic technologies. She holds unique expertise in developing novel molecular pipelines and translating research models to the clinical sphere. Dr D’Silva’s major focus are developing biomarker platforms that can improve diagnosis and facilitate timely interventions. Her multi-disciplinary research program serves one main goal: identify the molecular basis and mechanism of disease in children affected with rare disorders to enable precision and preventative medicine.
As a translational neuroscientist, Dr D’Silva is extraordinarily well-placed to lead research programs that generate novel ideas as well as build resources and capability for the clinical applications of genomics in the field of rare neurological diseases. She is uniquely positioned to bring together valuable human biospecimens and comprehensive patient phenotyping, to develop innovative ways of providing the best possible care from the time of diagnosis, through treatment and beyond to people with neuromuscular, neurodevelopmental, or rare neurogenetic diseases. Dr D’Silva has successfully obtained >$1.5M, in total research income as a named investigator from diverse sources including highly competitive (NHMRC) and philanthropy partnership grants to achieve this work.
Abstracts this author is presenting: